Suchergebnisse - "*Mouth Neoplasms"

PubPharm (2.540)

11

A qualitative study on experiences of stigma among postoperative oral cancer patients

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2024

von Zhu, J. | Tan, C. | Guo, J. | +2

12

A qualitative study on experiences of stigma among postoperative oral cancer patients

enthalten in: Supportive care in cancer | 2024

von Zhu, J. | Tan, C. | Guo, J. | +2

13

To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer : Phase I Study of Safety and Feasibility of Ayurvedic Oral Cannabis Preparation in the Peri-operative Period in Breast and Oral Cavity Squamous Cell Cancer

enthalten in: ClinicalTrials.gov | 2024

14

A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery : Intraoperative Visualization of Oral Cavity Squamous Cell Carcinoma and High-Grade Dysplasia With Tozuleristide, a Fluorescent Tumor Marking Agent

enthalten in: ClinicalTrials.gov | 2024

15

Oral-Gut-Estrobolome Axis May Exert a Selective Impact on Oral Cancer

enthalten in: Journal of dental research | 2024

von Tatullo, M. | Nor, J. | Orrù, G. | +3

16

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma : A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

enthalten in: ClinicalTrials.gov | 2024

17

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin : Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin

enthalten in: ClinicalTrials.gov | 2024

18

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers : A Phase II/III Trial of Chemotherapy + Cetuximab vs Chemotherapy + Bevacizumab vs Atezolizumab + Bevacizumab Following Progression on Immune Checkpoint Inhibition in Recurrent/Metastatic Head and Neck Cancers

enthalten in: ClinicalTrials.gov | 2024

19

Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment : A Multi-Centre Prospective Community-Based Observational Study on Prediction of Malignant Progression of Clinically Suspicious Oral Lesions With STRATICYTE

enthalten in: ClinicalTrials.gov | 2024

20

A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors : A Phase 2a, Double-blind, Placebo-controlled, Multi-center, Randomized Study Evaluating LSTA1 When Added to Standard of Care (SoC) Versus Standard of Care Alone in Subjects With Advanced Solid Tumors

enthalten in: ClinicalTrials.gov | 2024